Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We examined prevalences of previously diagnosed diabetes and undiagnosed diabetes and high risk for diabetes using recently suggested A1C criteria in the U.S. during 2003–2006. We compared these prevalences to those in earlier surveys and those using glucose criteria. RESEARCH DESIGN AND METHODS: In 2003–2006, the National Health and Nutrition Examination Survey included a probability sample of 14,611 individuals aged ≥12 years. Participants were classified on glycemic status by interview for diagnosed diabetes and by A1C, fasting, and 2-h glucose challenge values measured in subsamples. RESULTS: Using A1C criteria, the crude prevalence of total diabetes in adults aged ≥20 years was 9.6% (20.4 million), of which 19.0% was undiagnosed (7.8% diagnosed, 1.8% undiagnosed using A1C ≥6.5%). Another 3.5% of adults (7.4 million) were at high risk for diabetes (A1C 6.0 to <6.5%). Prevalences were disproportionately high in the elderly. Age-/sex-standardized prevalence was more than two times higher in non-Hispanic blacks and Mexican Americans versus non-Hispanic whites for diagnosed, undiagnosed, and total diabetes (P < 0.003); standardized prevalence at high risk for diabetes was more than two times higher in non-Hispanic blacks versus non-Hispanic whites and Mexican Americans (P < 0.00001). Since 1988–1994, diagnosed diabetes generally increased, while the percent of diabetes that was undiagnosed and the percent at high risk of diabetes generally decreased. Using A1C criteria, prevalences of undiagnosed diabetes and high risk of diabetes were one-third that and one-tenth that, respectively, using glucose criteria. CONCLUSIONS: Although A1C detects much lower prevalences than glucose criteria, hyperglycemic conditions remain high in the U.S., and elderly and minority groups are disproportionately affected.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“analyses of the fidelity of DM diagnosis using A1C have reported a lower sensitivity than FPG or 2-hour OGTT.4,5,7-10”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [8]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The epidemiologic studies that formed the basis for recommending A1C to diagnose diabetes included only adult populations (112).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [112]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The epidemiologic studies that formed the basis for the recommendations to use A1C and plasma glucose criteria to diagnose prediabetes and diabetes included only adult populations (113).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [113]
Experimental — accuracy not yet measuredIn the citing paper
“Following high-quality epidemiological studies, it was suggested that HbA1c could be used to diagnose diabetes, and this was subsequently endorsed by international guidelines.10”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 2×
“Blacks and Hispanics with IGT in the Diabetes Prevention Program had higher A1C levels than whites, after adjusting for glucose levels and other factors such as age, sex, education, blood pressure, BMI, hematocrit, and insulin resistance (10).”
BackgroundDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
SUDAAN User's Manual, Release 7.5,
Bieler, G. S., Barnwell, B., & Shah, B. V. (1997) · Cited by 1,273
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006
Cowie, C. C., Rust, K. F., Ford, E. S., Eberhardt, M. S., Byrd-Holt, D. D., Li, C., Williams, D. E., Gregg, E. W., Bainbridge, K. E., Saydah, S. H., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1296 · Cited by 1,154 · cited 2×
“Certain relationships by age and race/ ethnicity also differed between results based on A1C criteria (herein) and glucose criteria (8) (online appendix Table A1).”
ResultSelf-citationHerman, W. H., Ma, Y., Uwaifo, G., Haffner, S., Kahn, S. E., Horton, E. S., Lachin, J. M., Montez, M. G., Brenneman, T., Barrett-Connor, E., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2003 · Cited by 574 · cited 1×
“Blacks and Hispanics with IGT in the Diabetes Prevention Program had higher A1C levels than whites, after adjusting for glucose levels and other factors such as age, sex, education, blood pressure, BMI, hematocrit, and insulin resistance (10).”
BackgroundShort-term variability in measures of glycemia and implications for the classification of diabetes
Selvin, E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1545 · Cited by 402 · cited 1×
“Consequently, some prevalence estimates may be overstated (11).”
BackgroundEffect of Aging on A1C Levels in Individuals Without Diabetes
Pani, L. N., Korenda, L., Meigs, J. B., Driver, C., Chamany, S., Fox, C. S., Sullivan, L., D’Agostino, R. B., & Nathan, D. M. (2008) · Diabetes Care · doi:10.2337/dc08-0577 · Cited by 378
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
(2) Classification and diagnosis of diabetes
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s005 · Cited by 1,841
Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus, Seino, Y., Nanjo, K., Tajima, N., Kadowaki, T., Kashiwagi, A., Araki, E., Ito, C., Inagaki, N., Iwamoto, Y., et al. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00074.x · Cited by 1,772
“It has been pointed out in individual cases that there is a possibility of overlooking the disease if the diagnosis is made based on HbA1c alone [46].”
Background2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
2. Classification and Diagnosis of Diabetes
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s005 · Cited by 1,603
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Hampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., Avila Edwards, K. C., Eneli, I., Hamre, R., Joseph, M. M., et al. (2023) · Pediatrics · doi:10.1542/peds.2022-060640 · Cited by 1,389
Glucose Biosensors: An Overview of Use in Clinical Practice
Yoo, E.-H., & Lee, S.-Y. (2010) · Sensors · doi:10.3390/s100504558 · Cited by 1,137
“4 million) in 2003-2006 [1].”
2. Classification and Diagnosis of Diabetes
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s005 · Cited by 1,066
Temporal trends in the prevalence of diabetic kidney disease in the United States
de Boer, I. H. (2011) · JAMA · doi:10.1001/jama.2011.861 · Cited by 1,036
“5% or greater, or both.(2,8) Level of hemoglobin A1c of 6.”
BackgroundMethodInfluentialClinical manifestations of kidney disease among US adults with diabetes, 1988-2014
Afkarian, M., Zelnick, L. R., Hall, Y. N., Heagerty, P. J., Tuttle, K., Weiss, N. S., & de Boer, I. H. (2016) · JAMA · doi:10.1001/jama.2016.10924 · Cited by 1,026
Kashiwagi, A., Kasuga, M., Araki, E., Oka, Y., Hanafusa, T., Ito, H., Tominaga, M., Oikawa, S., Noda, M., Kawamura, T., et al. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00207.x · Cited by 901
Diabetes mellitus statistics on prevalence and mortality: facts and fallacies
Zimmet, P., Alberti, K. G., Magliano, D. J., & Bennett, P. H. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.105 · Cited by 785
Yang, Q., Cogswell, M. E., Flanders, W. D., Hong, Y., Zhang, Z., Loustalot, F., Gillespie, C., Merritt, R., & Hu, F. B. (2012) · JAMA · doi:10.1001/jama.2012.339 · Cited by 802
“3% have diabetes, and more than 50% of persons with diagnosed diabetes are also obese.(51-55) The high prevalence of obesity and the increasing prevalence of diabetes could offset the positive effects of the decline in other CVD risk factors(56,57) and continue to slow improvements in cardiovascular health.”
BackgroundGeiss, L. S., Wang, J., Cheng, Y. J., Thompson, T. J., Barker, L., Li, Y., Albright, A. L., & Gregg, E. W. (2014) · JAMA · doi:10.1001/jama.2014.11494 · Cited by 672
Self-citationJoseph, J. J., Deedwania, P., Acharya, T., Aguilar, D., Bhatt, D. L., Chyun, D. A., Di Palo, K. E., Golden, S. H., Sperling, L. S., & on behalf of the American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, T. A. V. B. C. O. C. C. A. C. O. H. (2022) · Circulation · doi:10.1161/cir.0000000000001040 · Cited by 660
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Trends in Prevalence of Chronic Kidney Disease in the United States
Murphy, D., McCulloch, C. E., Lin, F., Banerjee, T., Bragg-Gresham, J. L., Eberhardt, M. S., Morgenstern, H., Pavkov, M. E., Saran, R., Powe, N. R., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0273 · Cited by 616
“There is some misclassification of diabetes status since we used A1c and not fasting glucose levels or 2-h glucose challenge values to define diabetes (39, 41) and some patients with prediabetes may be prescribed metformin.”
Seino, Y., Nanjo, K., Tajima, N., Kadowaki, T., Kashiwagi, A., Araki, E., Ito, C., Inagaki, N., Iwamoto, Y., Kasuga, M., et al. (2010) · Diabetology International · doi:10.1007/s13340-010-0006-7 · Cited by 614
Targher, G., Tilg, H., & Byrne, C. D. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00020-0 · Cited by 586
The Growing Epidemic of Diabetes Mellitus
Lovic, D., Piperidou, A., Zografou, I., Grassos, H., Pittaras, A., & Manolis, A. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161117666190405165911 · Cited by 504
Chiang, J. L., Maahs, D. M., Garvey, K. C., Hood, K. K., Laffel, L. M., Weinzimer, S. A., Wolfsdorf, J. I., & Schatz, D. (2018) · Diabetes Care · doi:10.2337/dci18-0023 · Cited by 509
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations
Mendenhall, E., Kohrt, B. A., Norris, S. A., Ndetei, D., & Prabhakaran, D. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30402-6 · Cited by 556
Cruz-Flores, S., Rabinstein, A., Biller, J., Elkind, M. S. V., Griffith, P., Gorelick, P. B., Howard, G., Leira, E. C., Morgenstern, L. B., Ovbiagele, B., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182213e24 · Cited by 507
Handelsman, Y., Mechanick, J. I., Blonde, L., Grunberger, G., Bloomgarden, Z. T., Bray, G. A., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.s2.1 · Cited by 513
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
Prevalence of and Risk Factors for Diabetic Macular Edema in the United States
Varma, R., Bressler, N. M., Doan, Q. V., Gleeson, M., Danese, M., Bower, J. K., Selvin, E., Dolan, C., Fine, J., Colman, S., et al. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.2854 · Cited by 423
Wheeler, E., Leong, A., Liu, C.-T., Hivert, M.-F., Strawbridge, R. J., Podmore, C., Li, M., Yao, J., Sim, X., Hong, J., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002383 · Cited by 408
Prediabetes and what it means: the epidemiological evidence
Echouffo-Tcheugui, J. B., & Selvin, E. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102644 · Cited by 406
“NAVIGATOR (47) International 2010 IGT and IFG Valsartan versus placebo 9,306 5 14% (8, 20)”
BackgroundType-2 diabetes mellitus and cardiovascular disease
Henning, R. J. (2018) · Future Cardiology · doi:10.2217/fca-2018-0045 · Cited by 398
The Pros and Cons of Diagnosing Diabetes With A1C
Bonora, E., & Tuomilehto, J. (2011) · Diabetes Care · doi:10.2337/dc11-s216 · Cited by 379
Nguyen, N. T., Nguyen, X.-M. T., Lane, J., & Wang, P. (2011) · Obesity Surgery · doi:10.1007/s11695-010-0335-4 · Cited by 385
“4 million in the US and many diabetic individuals are obese [1].”
BackgroundKristensen, S. L., Preiss, D., Jhund, P. S., Squire, I., Cardoso, J. S., Merkely, B., Martinez, F., Starling, R. C., Desai, A. S., Lefkowitz, M. P., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002560 · Cited by 359
Low Testosterone in Men with Type 2 Diabetes: Significance and Treatment
Grossmann, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0118 · Cited by 350
The physiology of endocrine systems with ageing
van den Beld, A. W., Kaufman, J.-M., Zillikens, M. C., Lamberts, S. W. J., Egan, J. M., & van der Lely, A. J. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30026-3 · Cited by 349
Geiss, L. S., Li, Y., Hora, I., Albright, A., Rolka, D., & Gregg, E. W. (2019) · Diabetes Care · doi:10.2337/dc18-1380 · Cited by 319
Self-citationGregg, E. W., Zhuo, X., Cheng, Y. J., Albright, A. L., Narayan, K. M. V., & Thompson, T. J. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70161-5 · Cited by 301
Self-citationKocher, T., König, J., Borgnakke, W. S., Pink, C., & Meisel, P. (2018) · Periodontology 2000 · doi:10.1111/prd.12235 · Cited by 293
Trends in Death Rates Among U.S. Adults With and Without Diabetes Between 1997 and 2006
Gregg, E. W., Cheng, Y. J., Saydah, S., Cowie, C., Garfield, S., Geiss, L., & Barker, L. (2012) · Diabetes Care · doi:10.2337/dc11-1162 · Cited by 303
Self-citationThe Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women
Cote, M. L., Ruterbusch, J. J., Olson, S. H., Lu, K., & Ali-Fehmi, R. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0316 · Cited by 272
Nanotechnology in glucose monitoring: Advances and challenges in the last 10 years
Scognamiglio, V. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.02.043 · Cited by 266
“Moreover, the World Health Organization (WHO) has predicted that people with diabetes worldwide were approximately 171 million in 2000, and this is expected to increase to 366 million by 2030 (Narayan et al., 2006; Cowie et al., 2010; Shaw et al., 2010).”
BackgroundLarge-Scale Gene-Centric Meta-Analysis across 39 Studies Identifies Type 2 Diabetes Loci
Saxena, R., Elbers, C. C., Guo, Y., Peter, I., Gaunt, T. R., Mega, J. L., Lanktree, M. B., Tare, A., Castillo, B. A., Li, Y. R., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.12.022 · Cited by 270
Cardiorespiratory Fitness and Cardiovascular Disease Prevention: an Update
Al-Mallah, M. H., Sakr, S., & Al-Qunaibet, A. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0711-4 · Cited by 231
Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus
Ortiz-Martínez, M., González-González, M., Martagón, A. J., Hlavinka, V., Willson, R. C., & Rito-Palomares, M. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01453-4 · Cited by 203
“According to the US National Health and Nutrition Examination Survey (NHANES), HbA1c testing using the ≥ 6.5% diagnostic threshold only diagnoses 30% of the total T2DM cases identified through HbA1c, FPG, and OGTT [10, 17].”
BackgroundInfluentialFwu, C.-W., Eggers, P. W., Kimmel, P. L., Kusek, J. W., & Kirkali, Z. (2013) · Kidney International · doi:10.1038/ki.2012.419 · Cited by 221
Utility of Hemoglobin A1c for Diagnosing Prediabetes and Diabetes in Obese Children and Adolescents
Nowicka, P., Santoro, N., Liu, H., Lartaud, D., Shaw, M. M., Goldberg, R., Guandalini, C., Savoye, M., Rose, P., & Caprio, S. (2011) · Diabetes Care · doi:10.2337/dc10-1984 · Cited by 209
Gestational diabetes: risks, management, and treatment options
Kim, C. (2010) · International Journal of Women's Health · doi:10.2147/ijwh.s13333 · Cited by 192
Danaei, G., Fahimi, S., Lu, Y., Zhou, B., Hajifathalian, K., Di Cesare, M., Lo, W., Reis-Santos, B., Cowan, M., Shaw, J., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00129-1 · Cited by 191
Molecular and metabolic mechanisms of cardiac dysfunction in diabetes
Mandavia, C. H., Aroor, A. R., DeMarco, V. G., & Sowers, J. R. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.10.028 · Cited by 190
“Diabetes is a major chronic disease affecting more than 25 million Americans, or greater than 8% of the current US population (16).”
Werner, E. F., Pettker, C. M., Zuckerwise, L., Reel, M., Funai, E. F., Henderson, J., & Thung, S. F. (2012) · Diabetes Care · doi:10.2337/dc11-1643 · Cited by 182
Stokes, A., & Preston, S. H. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170219 · Cited by 166
“[2, 3] Trends are similar when HbA1c is the sole criterion.[4, 5] The prevalence of self-reported diagnoses rose very rapidly between 1990 and 2008 and slowly during the 1980’s and between 2008 and 2012.”
BackgroundLorenzo, C., Wagenknecht, L. E., Hanley, A. J. G., Rewers, M. J., Karter, A. J., & Haffner, S. M. (2010) · Diabetes Care · doi:10.2337/dc10-0679 · Cited by 176
Heart Disease Death Rates Among Blacks and Whites Aged ≥35 Years — United States, 1968–2015
Van Dyke, M., Greer, S., Odom, E., Schieb, L., Vaughan, A., Kramer, M., & Casper, M. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6705a1 · Cited by 165
“On average, when compared with whites, blacks have higher prevalences of cardiovascular risk factors such as obesity (26), diabetes (27), hypertension (28), physical inactivity (25), and short sleep duration (24).”
BackgroundBrunisholz, K., Briot, P., Hamilton, S., Joy, E., Lomax, M., Barton, N., Cunningham, R., Cannon, W., & Savitz, L. (2014) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s69000 · Cited by 167
Buysschaert, M., & Bergman, M. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.11.002 · Cited by 175
The impact of gestational diabetes and maternal obesity on the mother and her offspring
Catalano, P. M. (2010) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174410000115 · Cited by 169
Unrecognized glucose intolerance is common in pulmonary arterial hypertension
Pugh, M. E., Robbins, I. M., Rice, T. W., West, J. D., Newman, J. H., & Hemnes, A. R. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.02.016 · Cited by 157
“HbA1c may not detect all glucose intolerant patients [12] and use of HbA1c may actually underestimate the burden of glucose intolerance and pre-diabetes.”
BackgroundEvaluating empirical bounds on complex disease genetic architecture
Agarwala, V., Flannick, J. A., Sunyaev, S. R., & Altshuler, D. (2013) · Nature Genetics · doi:10.1038/ng.2804 · Cited by 162
Exclusion of Older Adults from Ongoing Clinical Trials About Type 2 Diabetes Mellitus
Cruz-Jentoft, A. J., Carpena‐Ruiz, M., Montero‐Errasquín, B., Sánchez-Castellano, C., & Sánchez, E. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12215 · Cited by 143
Bakalov, V. K., Gutin, L. S., Cheng, C. M., Zhou, J., Sheth, P., Shah, K. R., Arepalli, S., Vanderhoof, V. H., Nelson, L. M., & Bondy, C. A. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.01.015 · Cited by 141
Heidemann, C., Du, Y., Paprott, R., Haftenberger, M., Rathmann, W., & Scheidt‐Nave, C. (2015) · Diabetic Medicine · doi:10.1111/dme.13008 · Cited by 144
Spousal diabetes as a diabetes risk factor: A systematic review and meta-analysis
Leong, A., Rahme, E., & Dasgupta, K. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-12 · Cited by 140
“Moreover, 30% to 40% of diabetes cases remain undiagnosed [3-6].”
BackgroundDiabetes Prevention Program Research Group (2015) · Diabetes Care · doi:10.2337/dc14-0886 · Cited by 139
Guo, F., Moellering, D. R., & Garvey, W. T. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0128 · Cited by 139
Rosenzweig, J. L., Bakris, G. L., Berglund, L., Hivert, M., Horton, E. S., Kalyani, R. R., Murad, M. H., & Vergès, B. L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01338 · Cited by 145
Pitfalls in the use of HbA1c as a diagnostic test: the ethnic conundrum
Dagogo-Jack, S. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.126 · Cited by 131
Morrison, F. J. R., Shubina, M., & Turchin, A. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.400 · Cited by 125
“D IABETES MELLITUS (DM) IS increasingly common in the United States and worldwide.(1,2) Elevated serum glucose, blood pressure (BP), and low-density lipoprotein cholesterol (LDL-C) (hereafter referred to as hemoglobin A1c, BP, and LDL-C) values are associated with increased risk of microvascular and macrovascular comp…”
BackgroundDiabetes and Congenital Heart Defects
Simeone, R. M., Devine, O. J., Marcinkevage, J. A., Gilboa, S. M., Razzaghi, H., Bardenheier, B. H., Sharma, A. J., & Honein, M. A. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.09.002 · Cited by 124
“The prevalence of type 1 and type 2 diabetes has increased in the U.S. among men and women of all ages, 24,25 including reproductive-aged women and women who become pregnant.”
BackgroundMendenhall, E. (2015) · Medical Anthropology Quarterly · doi:10.1111/maq.12215 · Cited by 123
Validity of diabetes self-reports in the Women’s Health Initiative
Jackson, J., DeFor, T. A., Crain, A. L., Kerby, T. J., Strayer, L., Lewis, C. E., Whitlock, E. P., Williams, S. B., Vitolins, M. Z., Rodabough, R. J., et al. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000189 · Cited by 125
Food insecurity is associated with diabetes self‐care behaviours and glycaemic control
Heerman, W. J., Wallston, K. A., Osborn, C. Y., Bian, A., Schlundt, D. G., Barto, S., & Rothman, R. L. (2015) · Diabetic Medicine · doi:10.1111/dme.12896 · Cited by 121
DeBoer, M. D., Gurka, M. J., Woo, J. G., & Morrison, J. A. (2015) · Diabetologia · doi:10.1007/s00125-015-3759-5 · Cited by 120
“In addition, there appear to be differences in howMetSmanifests on the basis of sex and race/ethnicity, with African-American men in particular being classified as having a low prevalence of MetS despite having high rates of type 2 diabetes and death fromCVD [18–24].”
BackgroundNorris, G. H., Porter, C. M., Jiang, C., Millar, C. L., & Blesso, C. N. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.09.017 · Cited by 125
Khan, R. U., Ahmad, R., Rai, P., Jang, L., Yun, J.-H., Yu, Y., Hahn, Y., & Lee, I. (2014) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2014.06.128 · Cited by 119
Work-related stress and Type 2 diabetes: systematic review and meta-analysis
Cosgrove, M., Sargeant, L. A., Caleyachetty, R., & Griffin, S. J. (2012) · Occupational Medicine · doi:10.1093/occmed/kqs002 · Cited by 118
“7% (2005–2006) [2] and similar figures pertain to England [3].”
BackgroundThe Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men
Snyder, P. J., Ellenberg, S. S., Cunningham, G. R., Matsumoto, A. M., Bhasin, S., Barrett-Connor, E. L., Gill, T. M., Farrar, J. T., Cella, D. F., Rosen, R. C., et al. (2014) · Clinical Trials · doi:10.1177/1740774514524032 · Cited by 122
“As men age, they also experience decreased muscle mass [3,4] and mobility [5], decreased sexual function [6], decreased energy, anemia [7], decline in memory and other cognitive functions [8], decreased bone mineral density [9] and increased fractures [10], increased fat mass [11], and impaired glucose tolerance [12].”
BackgroundClinical utility of metabolic syndrome severity scores: considerations for practitioners
DeBoer, M. D., & Gurka, M. J. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s101624 · Cited by 122
“27 The low prevalence of traditional MetS among non-Hispanic Blacks is surprising given a higher degree of insulin resistance 30,31 and high rates of T2DM 32 and death from CVD 2 in this group.”
Meijnikman, A. S., De Block, C. E. M., Dirinck, E., Verrijken, A., Mertens, I., Corthouts, B., & Van Gaal, L. F. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.165 · Cited by 112
Identifying Dysglycemic States in Older Adults: Implications of the Emerging Use of Hemoglobin A1c
Lipska, K. J., de Rekeneire, N., Ness, P. H. V., Johnson, K., Kanaya, A. M., Koster, A., Strotmeyer, E. S., Goodpaster, B. H., Harris, T. B., Gill, T. M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1171 · Cited by 111
Gurka, M. J., Golden, S. H., Musani, S. K., Sims, M., Vishnu, A., Guo, Y. M., Cardel, M. I., Pearson, T. A., & DeBoer, M. D. (2017) · Diabetologia · doi:10.1007/s00125-017-4267-6 · Cited by 110
“Indeed, it has been noted that the metabolic syndrome did not provide adequate risk prediction among black participants [26, 27], who have a relatively low prevalence of the metabolic syndrome as assessed using traditional binary criteria despite having high rates of diabetes [28] and CHD [29], as though the metabolic…”
Metformin, beyond an insulin sensitizer, targeting heart and pancreatic β cells
Yang, X., Xu, Z., Zhang, C., Cai, Z., & Zhang, J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.09.019 · Cited by 108
Hyperglycaemia, oxidative stress and inflammatory markers
Butkowski, E., & Jelinek, H. F. (2016) · Redox Report · doi:10.1080/13510002.2016.1215643 · Cited by 111
“5% may represent a high risk for the development of diabetes (if used for diagnostic purposes); however, there is still a continuum of risk associated with normal levels of HbA1c below 6%.[39] If a lower cut-off of HbA1c is used, then the likelihood of missing DM is also increased.”
BackgroundGyberg, V., Bacquer, D. D., Kotseva, K., Backer, G. D., Schnell, O., Sundvall, J., Tuomilehto, J., Wood, D., & Rydén, L. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv008 · Cited by 103
Diagnosis and Classification of Diabetes
(2010) · Wiley eBooks · doi:10.1002/9781444391374.ch3 · Cited by 101
Timing and Duration of Obesity in Relation to Diabetes
The, N. S., Richardson, A. S., & Gordon‐Larsen, P. (2012) · Diabetes Care · doi:10.2337/dc12-0536 · Cited by 101
Leong, A., Dasgupta, K., Bernatsky, S., Lacaille, D. V., Aviña-Zubieta, A., & Rahme, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075256 · Cited by 106
“It has been previously estimated that approximately one third of diabetes cases remain undiagnosed [44–46].”
BackgroundCheng, L. J., Wang, W., Lim, S. T., & Wu, X. V. (2019) · Journal of Clinical Nursing · doi:10.1111/jocn.14795 · Cited by 111
Metadata
- Authors
- Cowie, C. C., Rust, K. F., Byrd-Holt, D. D., Gregg, E. W., Ford, E. S., Geiss, L. S., Bainbridge, K. E., & Fradkin, J. E.
- Affiliations
- National Institutes of Health (US)
- Westat (United States) (US)
- Social and Scientific Systems (United States) (US)
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Cowie, Catherine C.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-01-19
- Volume
- 33
- Issue
- 3
- Pages
- 562-568
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2827508
- OpenAlex
- W2156942915
- Cited by
- 689
- References
- 14
- Citations by year
- 2026: 7 · 2025: 16 · 2024: 26 · 2023: 22 · 2022: 29 · 2021: 37 · 2020: 34 · 2019: 30 · 2018: 54 · 2017: 39 · 2016: 48 · 2015: 57 · 2014: 76 · 2013: 65 · 2012: 60
- FWCI
- 51.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- diabetes prevalence, undiagnosed diabetes, diabetes risk, HbA1c, glucose challenge test, fasting blood glucose, racial and ethnic disparities, older adults, NHANES
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Diabetes Mellitus, Female, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Male, Middle Aged, Population, Prediabetic State, Risk Factors, United States, Prevalence, Young Adult, Delayed Diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.